Publications

Filters: First Letter Of Last Name is S  [Clear All Filters]
2020
Nemeth J, Olson GS, Rothchild AC, et al. "Contained Mycobacterium tuberculosis infection induces concomitant and heterologous protection." PLoS Pathog. 2020;16(7):e1008655.
Peters JS, Ismail N, Dippenaar A, et al. "Genetic Diversity in Clinical Isolates and Resulting Outcomes of Tuberculosis Infection and Disease." Annu Rev Genet. 2020.
Peterson EJR, Abidi AA, Arrieta-Ortiz ML, et al. "Intricate Genetic Programs Controlling Dormancy in Mycobacterium tuberculosis." Cell Rep. 2020;31(4):107577.
Peterson EJR, Abidi AA, Arrieta-Ortiz ML, et al. "Intricate Genetic Programs Controlling Dormancy in Mycobacterium tuberculosis." Cell Rep. 2020;31(4):107577.
Rahil Z, Leylek R, Schürch CM, et al. "Landscape of coordinated immune responses to H1N1 challenge in humans." J Clin Invest. 2020;130(11):5800-5816.
Rahil Z, Leylek R, Schürch CM, et al. "Landscape of coordinated immune responses to H1N1 challenge in humans." J Clin Invest. 2020;130(11):5800-5816.
Ma S, Morrison R, Hobbs SJ, et al. "Transcriptional regulator-induced phenotype screen reveals drug potentiators in Mycobacterium tuberculosis." Nat Microbiol. 2020.
Ma S, Morrison R, Hobbs SJ, et al. "Transcriptional regulator-induced phenotype screen reveals drug potentiators in Mycobacterium tuberculosis." Nat Microbiol. 2020.
Plumlee CR, Duffy FJ, Gern BH, et al. "Ultra-low Dose Aerosol Infection of Mice with Mycobacterium tuberculosis More Closely Models Human Tuberculosis." Cell Host Microbe. 2020.
Plumlee CR, Duffy FJ, Gern BH, et al. "Ultra-low Dose Aerosol Infection of Mice with Mycobacterium tuberculosis More Closely Models Human Tuberculosis." Cell Host Microbe. 2020.
2019
Delahaye JL, Gern BH, Cohen SB, et al. "BCG-induced T cells shape Mycobacterium tuberculosis infection before reducing the bacterial burden." bioRxiv. 2019.
Delahaye JL, Gern BH, Cohen SB, et al. "Cutting Edge: Bacillus Calmette–Guérin–Induced T Cells Shape Mycobacterium tuberculosis Infection before Reducing the Bacterial Burden." The Journal of Immunology. 2019;203:807-812.
Adams KN, Verma AKumar, Gopalaswamy R, et al. "Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin Tolerance." The Journal of Infectious Diseases. 2019;219:1554-1558.
Adams KN, Verma AKumar, Gopalaswamy R, et al. "Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin Tolerance." The Journal of Infectious Diseases. 2019;219:1554-1558.
Duffy FJ, Weiner J, Hansen S, et al. "Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome." Front Immunol. 2019;10:527.
Duffy FJ, Weiner J, Hansen S, et al. "Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome." Front Immunol. 2019;10:527.
Duffy FJ, Weiner J, Hansen S, et al. "Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome." Front Immunol. 2019;10:527.
Duffy FJ, Weiner J, Hansen S, et al. "Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome." Front Immunol. 2019;10:527.
Ma S, Jaipalli S, Larkins-Ford J, et al. "Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy against Tuberculosis." mBio. 2019;10(6).